Revvity - 42 Year Stock Price History | RVTY
Historical daily share price chart and data for Revvity since 1983 adjusted for splits and dividends. The latest closing stock price for Revvity as of March 27, 2025 is 107.34.
- The all-time high Revvity stock closing price was 199.71 on December 31, 2021.
- The Revvity 52-week high stock price is 129.50, which is 20.6% above the current share price.
- The Revvity 52-week low stock price is 97.31, which is 9.3% below the current share price.
- The average Revvity stock price for the last 52 weeks is 114.28.
| Revvity Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 115.6859 | 112.0000 | 126.8400 | 106.9800 | 107.3400 | -3.83% |
| 2024 | 111.8942 | 110.1436 | 127.6753 | 99.2577 | 111.6100 | 2.37% |
| 2023 | 116.6316 | 140.4511 | 143.7509 | 81.8671 | 109.0265 | -21.86% |
| 2022 | 149.7563 | 190.9050 | 190.9050 | 116.3742 | 139.5356 | -30.13% |
| 2021 | 158.1494 | 144.2642 | 199.7054 | 119.3751 | 199.7054 | 40.37% |
| 2020 | 106.2368 | 97.7435 | 146.6437 | 66.0022 | 142.2714 | 48.19% |
| 2019 | 88.8494 | 75.8118 | 99.7459 | 71.7413 | 96.0034 | 24.01% |
| 2018 | 79.3809 | 72.5901 | 95.7922 | 70.8346 | 77.4183 | 7.80% |
| 2017 | 62.6675 | 51.8079 | 72.5214 | 50.4869 | 71.8142 | 40.85% |
| 2016 | 50.5789 | 50.9821 | 55.5767 | 40.3652 | 50.9866 | -2.12% |
| 2015 | 48.3112 | 42.6242 | 52.8588 | 41.2418 | 52.0906 | 23.21% |
| 2014 | 42.7635 | 39.3230 | 46.4935 | 38.4383 | 42.2762 | 6.75% |
| 2013 | 33.8183 | 30.5734 | 39.7168 | 29.0346 | 39.6015 | 30.96% |
| 2012 | 25.9897 | 19.4169 | 30.7639 | 19.2002 | 30.2399 | 60.41% |
| 2011 | 22.3228 | 24.1260 | 26.6552 | 16.4855 | 18.8514 | -21.62% |
| 2010 | 20.9312 | 18.9787 | 24.3496 | 17.5430 | 24.0515 | 27.04% |
| 2009 | 15.2954 | 12.8007 | 19.2332 | 9.9879 | 18.9327 | 50.67% |
| 2008 | 21.8581 | 22.7994 | 26.7298 | 11.8702 | 12.5658 | -45.92% |
| 2007 | 23.1140 | 19.3359 | 26.6018 | 18.9031 | 23.2369 | 18.34% |
| 2006 | 18.6635 | 20.9170 | 21.0595 | 15.7470 | 19.6362 | -4.41% |
| 2005 | 18.1940 | 19.0011 | 20.8036 | 15.5999 | 20.5421 | 6.19% |
| 2004 | 16.6180 | 14.8655 | 19.6893 | 13.4853 | 19.3452 | 33.79% |
| 2003 | 10.9410 | 7.2964 | 15.8142 | 6.1725 | 14.4589 | 112.10% |
| 2002 | 10.4258 | 28.0338 | 29.0193 | 3.6110 | 6.8171 | -75.70% |
| 2001 | 25.7940 | 38.5308 | 39.7622 | 17.0070 | 28.0578 | -32.73% |
| 2000 | 29.7228 | 16.3123 | 47.4684 | 15.3518 | 41.7086 | 154.15% |
| 1999 | 12.9899 | 11.1414 | 17.2452 | 10.0092 | 16.4107 | 52.59% |
| 1998 | 10.3019 | 7.8946 | 12.8834 | 7.4447 | 10.7547 | 36.69% |
| 1997 | 7.6855 | 7.3152 | 8.9371 | 6.7621 | 7.8682 | 6.28% |
| 1996 | 7.4708 | 8.5457 | 8.9157 | 6.0236 | 7.4035 | -14.69% |
| 1995 | 6.1276 | 5.0523 | 8.6781 | 4.6255 | 8.6781 | 77.85% |
| 1994 | 5.4504 | 5.9260 | 6.3919 | 4.7938 | 4.8795 | -20.48% |
| 1993 | 6.7642 | 6.4684 | 8.0260 | 5.3426 | 6.1363 | -3.88% |
| 1992 | 7.3688 | 7.7091 | 8.5022 | 5.8957 | 6.3838 | -19.47% |
| 1991 | 6.4309 | 4.9301 | 7.9274 | 4.8927 | 7.9274 | 64.01% |
| 1990 | 5.6020 | 5.2444 | 6.3054 | 4.3657 | 4.8335 | -6.48% |
| 1989 | 4.9094 | 4.2604 | 5.5302 | 4.2604 | 5.1684 | 20.77% |
| 1988 | 4.8042 | 4.9348 | 5.6377 | 4.0564 | 4.2797 | -11.97% |
| 1987 | 5.1312 | 4.1135 | 6.5160 | 4.1135 | 4.8617 | 18.19% |
| 1986 | 4.9572 | 5.5696 | 6.2059 | 4.0771 | 4.1135 | -26.39% |
| 1985 | 5.4695 | 4.5867 | 6.1884 | 4.5867 | 5.5885 | 21.38% |
| 1984 | 4.4794 | 4.6959 | 5.1866 | 3.8586 | 4.6042 | -2.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.985B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.904B | 28.19 |
| Elevance Health (ELV) | United States | $87.590B | 11.69 |
| CVS Health (CVS) | United States | $79.455B | 11.63 |
| Cencora (COR) | United States | $47.362B | 17.19 |
| DiDi Global (DIDIY) | China | $23.670B | 0.00 |
| Natera (NTRA) | United States | $20.908B | 0.00 |
| ICON (ICLR) | Ireland | $16.429B | 14.61 |
| BioMerieux (BMXMF) | France | $13.758B | 0.00 |
| Viatris (VTRS) | United States | $13.595B | 4.19 |
| Doximity (DOCS) | United States | $13.537B | 70.40 |
| Solventum (SOLV) | United States | $13.178B | 0.00 |
| Avantor (AVTR) | United States | $11.895B | 17.47 |
| CochLear (CHEOY) | Australia | $11.072B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
| HealthEquity (HQY) | United States | $9.484B | 47.58 |
| Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
| Organon (OGN) | United States | $3.884B | 3.96 |
| Sotera Health (SHC) | United States | $3.814B | 20.40 |
| BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
| Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
| Concentras Parent (CON) | United States | $2.951B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
| Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Progyny (PGNY) | United States | $1.961B | 39.71 |
| Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Premier (PINC) | United States | $1.690B | 10.82 |
| Agilon Health (AGL) | United States | $1.500B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
| CareDx (CDNA) | United States | $1.146B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
| Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
| Embecta (EMBC) | United States | $0.798B | 5.47 |
| Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| MultiPlan (MPLN) | United States | $0.472B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| DocGo (DCGO) | United States | $0.453B | 17.08 |
| InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
| Enhabit (EHAB) | United States | $0.406B | 35.09 |
| QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
| Nutex Health (NUTX) | United States | $0.314B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
| Biodesix (BDSX) | United States | $0.122B | 0.00 |
| So-Young (SY) | China | $0.116B | 19.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
| ModivCare (MODV) | United States | $0.071B | 3.85 |
| Oncology Institute (TOI) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |